Catalyst Wire Dossier Catalyst Wire Dossier

Self-amplifying RNA vaccine against Crimean-Congo hemorrhagic fever

· HDT Bio
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Self-amplifying RNA vaccine against Crimean-Congo hemorrhagic fever, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever [Phase 1]

See pricing